Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Pimitespib + Imatinib

NCT05245968

Taiho Pharmaceutical · Phase 1 · Active, not recruiting · Enrollment 78

NCT05245968

Catalyst Primary completion. 12.2026. ClinicalTrials.gov primary completion date. This is a registry date, not a company readout.

ArmReported safety

A count stays a count. This page does not turn a count into a percent.